EUVIMEDEUVIMED entdecken
Crossref

Pelvic radiation disease: role of cancer nurses in patient assessment and self-management

Diana M Greenfield, Sara Faithfull

Cancer Nursing Practice · 03.11.2025 · 24 (6) · 33-41

DOI: 10.7748/cnp.2025.e1889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Nursing Practice, online erschienen am 29.07.2025. Verfasst von Diana M Greenfield und 1 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pelvic radiation disease (PRD) is a collection of signs and symptoms that can occur after a person has received radiotherapy for gynaecological, colon, rectal, prostate or another type of cancer occurring in the pelvic region. As more people live with and beyond cancer, it is increasingly important to consider patients’ risk factors for late effects of treatments such as pelvic radiotherapy, assess patients for potential symptoms of PRD and provide them with appropriate interventions, with a particular focus on self-management. This article describes common complications of pelvic radiotherapy and discusses the simpler aspects of PRD assessment and management while providing guidance on referring patients with severe or complex symptoms for specialist support.

Zitieren

APA

Greenfield, D. M., & Faithfull, S. (2025). Pelvic radiation disease: role of cancer nurses in patient assessment and self-management. Cancer Nursing Practice, 24(6), 33-41. https://doi.org/10.7748/cnp.2025.e1889

Vancouver

Greenfield DM, Faithfull S. Pelvic radiation disease: role of cancer nurses in patient assessment and self-management. Cancer Nursing Practice. 2025;24(6):33-41. doi:10.7748/cnp.2025.e1889

BibTeX
@article{Greenfield2025,
  author = {Greenfield, Diana M and Faithfull, Sara},
  title = {Pelvic radiation disease: role of cancer nurses in patient assessment and self-management},
  journal = {Cancer Nursing Practice},
  year = {2025},
  volume = {24},
  number = {6},
  pages = {33--41},
  doi = {10.7748/cnp.2025.e1889}
}
Kostenlos starten →